Marnix L.M. Lybeert - Concepedia

Author

Marnix L.M. Lybeert

Also Known As

H. Beerman, M L Lybeert, M L M Lybeert, M. L. M. LYBEERT, M. L. M. Lybeert, M. Lybeert, M.L Lybeert, M.L. Lybeert, M.L.M Lybeert, M.L.M. Lybeert

Publications

6.2K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Catharina Ziekenhuis Eindhoven Cancer Registry Instituut Verbeeten Medisch Spectrum Twente

About

Marnix L.M. Lybeert is an author at Radboud University Nijmegen specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	40	4.1K
2	Health Sciences	12	13	422
3	Public Health	4	4	124
4	Language Studies	1	1	24
5	Comparative Literature	1	1	24

Marnix L.M. Lybeert

Publications

Citations

H-Index

Page 1

	Year	Citations
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Carien L. Creutzberg, W L van Putten, P. Koper, The Lancet Gynecologic SurgerySurgical OncologyGynecological SurgeryRadiation TherapyMedicine	2000	1.7K
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond, New England Journal of Medicine	2015	605
Survival after relapse in patients with endometrial cancer: results from a randomized trial☆ Carien L. Creutzberg, Wim L.J. van Putten, P. Koper, Gynecologic Oncology Gynecological SurgeryMedicineCancer RecurrenceCancer ManagementGynecology	2003	367
Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma Carien L. Creutzberg, Remi A. Nout, Marnix L.M. Lybeert, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineRandomized Portec-1 TrialGynecologyEndometrial Carcinoma	2011	357
Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli, New England Journal of Medicine	2003	306
Outcome of High-Risk Stage IC, Grade 3, Compared With Stage I Endometrial Carcinoma Patients: The Postoperative Radiation Therapy in Endometrial Carcinoma Trial Carien L. Creutzberg, Wim L.J. van Putten, Carla C. Wárlám-Rodenhuis, Journal of Clinical Oncology	2004	277
Postoperative radiotherapy for Stage 1 endometrial carcinoma: Long-term outcome of the randomized PORTEC trial with central pathology review Astrid N. Scholten, Wim L.J. van Putten, H Beerman, International Journal of Radiation OncologyBiologyPhysics Gynecological SurgeryRadiation TherapyMedicineGynecologyStage 1	2005	241
Long-Term Outcome and Quality of Life of Patients With Endometrial Carcinoma Treated With or Without Pelvic Radiotherapy in the Post Operative Radiation Therapy in Endometrial Carcinoma 1 (PORTEC-1) Trial Remi A. Nout, Lonneke V. van de Poll‐Franse, Marnix L.M. Lybeert, Journal of Clinical Oncology	2011	238
The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial Carien L. Creutzberg, Wim L.J. van Putten, P. Koper, International Journal of Radiation OncologyBiologyPhysics MedicineCancer ManagementClinical EndpointGynecologyEndometrial Cancer	2001	194
Quality of life among long‐term non‐Hodgkin lymphoma survivors Floortje Mols, Neil K. Aaronson, A.J.J.M. Vingerhoets, Cancer	2007	105

Page 1